פרוטוקולים
High Risk Neuroblastoma Study 1.7 of SIOP-Europe – SIOPEN
10:40
אין תגובות
Lead Investigator: Study Ruth Ladenstein / Austria
Lead Investigator: Infant issues Adela Canete / Spain
Lead Investigator: Induction
Long term continuous infusion ch14.18/CHO plus s.c. aldesleukin – IL-2
10:08
אין תגובות
Protocol Number: 012010
Status: Version 3.0
ALL SCTped 2012 FORUM
15:05
אין תגובות
Allogeneic Stem Cell Transplantation in Children and Adolescents
with Acute Lymphoblastic Leukaemia
International Therapy Protocol
Version 2.1/January 29th, 2014
Prospective, open label, randomized phase II trial to assess a multimodal molecular targeted therapy in children, adolescent and young adults with relapsed or refractory high-risk neuroblastoma
10:51
אין תגובות
Study drugs: Rapamycin, Dasatinib, Temozolomide, Irinotecan
Version: 4.0
Status: Final
Date: 03.01.2014
Rapid COJEC versus standard induction therapies for high-risk neuroblastoma Protocol
16:42
אין תגובות
Peinemann F, Tushabe DA, Berthold F
INTERFANT-06 INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA
13:45
אין תגובות
Interfant-06, version 15,
Amendment 5.0: Aug 1, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study
16:20
אין תגובות
Kohler, J.A. et al.
European Journal of Cancer , Volume 49 , Issue 17 , 3671 - 3679
Amendment #5 for AREN03B2, Renal Tumors Classifications, Biology, and Banking Study
10:34
אין תגובות
Amendment #5 for AREN03B2
NOPHO-DBH AML 2012 Protocol
17:44
אין תגובות
RESEARCH STUDY FOR TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE MYELOID LEUKAEMIA
